 |
|
| An Aid in Cancer Detection | |
 |
|
| GenWay Biotech offers a novel test that can provide physicians with information to enable them to investigate and perform a cancer analysis. Features of the test include: | |
 Simple non-invasive blood test Quantitative assessment of tFFDP,PSA, CEA, and CA 15-3 The assessment of tumor fibrin and fibrinogen degradation products which have been associated with numerous types of cancers, such as bladder, brain, breast, cervical, colon, esophageal, leukemia, liver, lung, malignant lymphoma, oral, ovarian, pancreatic, rectal, stomach, thyroid, trophoblastic, and urinary malignancies Numerous clinical studies and research support for innovative markers
|
|
*Patients interested to learn more about GenWay’s CRA test should contact their physician. The laboratory services of GenWay are performed in Genway’s CLIA-registered and California Licensed laboratory (CLIA ID 05D1100497; Lab ID CLF 338815 |